![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 20, 15557-15562, May 19, 2000
From the Department of Pediatrics, Section of Pediatric Nephrology,
Tulane University School of Medicine,
New Orleans, Louisiana 70112
The bradykinin type 2 receptor (BK2) is a
developmentally regulated G protein-coupled receptor that mediates
diverse actions such as vascular reactivity, salt and water excretion,
inflammatory responses, and cell growth. However, little is known
regarding regulation of the BK2 gene. We report here that the rat BK2
receptor is transcriptionally regulated by the tumor suppressor protein p53. The 5'-flanking region of the rat BK2 gene contains
two p53-like binding sites: a sequence at
The Bradykinin Type 2 Receptor Is a Target for p53-mediated
Transcriptional Activation*
70 base pairs (P1 site)
that is conserved in the murine and human BK2 genes; and a sequence at
707 (P2) that is not. The P1 and P2 motifs bind specifically to p53,
as assessed by gel mobility shift assays. Transient transfection into
HeLa cells of a CAT reporter construct driven by 1.2-kilobases of the
BK2 gene 5'-flanking region demonstrated that the
BK2 promoter is dose dependently activated by co-expression
of wild-type p53. Co-expression of a dominant negative mutant p53
suppresses the activation of BK2 by wild-type p53. Promoter
truncation localized the p53-responsive element to the region between
38 and
94 base pairs encompassing the p53-binding P1 sequence.
Furthermore, p53-mediated activation of the BK2 promoter is
augmented by the transcriptional co-activators, CBP/p300.
Interestingly, removal of the P2 site by truncation or site-directed
deletion amplifies p53-mediated activation of the BK2
promoter. These results demonstrate that the rat BK2
promoter is a target for p53-mediated activation and suggest a new
physiological role for p53 in the regulation of G protein-coupled
receptor gene expression.
*
This work was supported by Grants DK-53595 and DK-56264 from
the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed:
Tulane University School of Medicine, 1430 Tulane Ave., New Orleans, LA
70112. Tel.: 504-588-5377; Fax: 504-584-1852; E-mail: seldahr@tmcpop.tmc.tulane.edu.
This article has been cited by other articles:
![]() |
S. S. El-Dahr, K. Aboudehen, and S. Dipp Bradykinin B2 receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1404 - F1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. El-Dahr, K. Aboudehen, and Z. Saifudeen Transcriptional control of terminal nephron differentiation Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1273 - F1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shen, L. M. Harrison-Bernard, A. J. Fuller, V. Vanderpool, Z. Saifudeen, and S. S. El-Dahr The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1140 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Van Bodegom, Z. Saifudeen, S. Dipp, S. Puri, B. S. Magenheimer, J. P. Calvet, and S. S. El-Dahr The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression J. Biol. Chem., October 20, 2006; 281(42): 31234 - 31244. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fan, J. Stefkova, and S. S. El-Dahr Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway Am J Physiol Renal Physiol, September 1, 2006; 291(3): F670 - F682. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Saifudeen, V. Diavolitsis, J. Stefkova, S. Dipp, H. Fan, and S. S. El-Dahr Spatiotemporal Switch from {Delta}Np73 to TAp73 Isoforms during Nephrogenesis: IMPACT ON DIFFERENTIATION GENE EXPRESSION J. Biol. Chem., June 17, 2005; 280(24): 23094 - 23102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Saifudeen, S. Dipp, H. Fan, and S. S. El-Dahr Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation Am J Physiol Renal Physiol, May 1, 2005; 288(5): F899 - F909. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fan, J. R. Harrell, S. Dipp, Z. Saifudeen, and S. S. El-Dahr A novel pathological role of p53 in kidney development revealed by gene-environment interactions Am J Physiol Renal Physiol, January 1, 2005; 288(1): F98 - F107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tan, F. N. Hutchison, and A. A. Jaffa Mechanisms of angiotensin II-induced expression of B2 kinin receptors Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H926 - H932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marks, Z. Saifudeen, S. Dipp, and S. S. El-Dahr Two Functionally Divergent p53-responsive Elements in the Rat Bradykinin B2 Receptor Promoter J. Biol. Chem., September 5, 2003; 278(36): 34158 - 34166. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Baptista, M. C. W. Avellar, R. C. Araujo, J. L. Pesquero, J. P. Schanstra, J. L. Bascands, J. P. Esteve, A. C. M. Paiva, M. Bader, and J. B. Pesquero Transcriptional Regulation of the Rat Bradykinin B2 Receptor Gene: Identification of a Silencer Element Mol. Pharmacol., December 1, 2002; 62(6): 1344 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Saifudeen, J. Marks, H. Du, and S. S. El-Dahr Spatial repression of PCNA by p53 during kidney development Am J Physiol Renal Physiol, October 1, 2002; 283(4): F727 - F733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. EL-DAHR, L. M. HARRISON-BERNARD, S. DIPP, I. V. YOSIPIV, and S. MELEG-SMITH Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development Physiol Genomics, September 8, 2000; 3(3): 121 - 131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |